Cytori Therapeutics Posts Study on Adipose Stem Cells to Treat Cardiovascular Disease
Related News: Heart / Cardio News, Stem Cell CompaniesCytori Therapeutics, Inc. has published of a summary of new research, by Cytori scientists on the potential of adipose stem cells in cardiac cell therapy.
This latest article, titled "Plasticity of human adipose stem cells toward endothelial cells and cardiomyocytes," will be appearing in the Cardiovascular Medicine Supplement of Nature Clinical Practice, is available online this week.
http://www.nature.com/clinicalpractice
"Publication of this review demonstrates the excitement within the scientific community about the potential of adipose stem cells, in particular the clinical applications in cardiovascular disease," said Marc H. Hedrick, M.D., President, Cytori Therapeutics. "The article illustrates that we and others have reported consistent findings regarding the mechanisms by which adipose stem cells improve cardiac function. Based on the abundance of data such as this, we look forward to initiating studies this year to evaluate adipose stem cells in a clinical setting for cardiac therapy."
Posted on March 2, 2006 01:42 PM